ロード中...
CAR therapy: the CD19 paradigm
Twenty-five years after its inception, the genetic engineering of T cells is now a therapeutic modality pursued at an increasing number of medical centers. This immunotherapeutic strategy is predicated on gene transfer technology to instruct T lymphocytes to recognize and reject tumor cells. Chimeri...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588281/ https://ncbi.nlm.nih.gov/pubmed/26325036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI80010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|